Menu
GeneBe

AZIN2

antizyme inhibitor 2

Basic information

Region (hg38): 1:33081103-33123492

Previous symbols: [ "ADC" ]

Links

ENSG00000142920NCBI:113451OMIM:608353HGNC:29957Uniprot:Q96A70AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

No genCC data.

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the AZIN2 gene.

  • Inborn genetic diseases (15 variants)
  • not provided (3 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the AZIN2 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
1
clinvar
1
missense
13
clinvar
2
clinvar
2
clinvar
17
nonsense
0
start loss
0
frameshift
0
inframe indel
0
splice donor/acceptor (+/-2bp)
0
splice region
0
non coding
0
Total 0 0 13 2 3

Variants in AZIN2

This is a list of pathogenic ClinVar variants found in the AZIN2 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
1-33082340-T-C not specified Uncertain significance (Aug 02, 2022)2207239
1-33084063-A-G not specified Uncertain significance (Feb 27, 2023)2489111
1-33092104-G-A not specified Uncertain significance (Jun 11, 2021)3132513
1-33092150-A-T not specified Uncertain significance (Mar 27, 2023)2530035
1-33092185-G-A not specified Uncertain significance (Sep 15, 2021)2209045
1-33092209-C-T not specified Uncertain significance (Jul 11, 2023)2610537
1-33092212-C-T Benign (Dec 28, 2017)791788
1-33093332-G-A not specified Uncertain significance (Apr 07, 2023)2534157
1-33093391-C-A Benign (May 31, 2018)770112
1-33094597-A-G not specified Uncertain significance (Dec 26, 2023)3132514
1-33094610-G-A not specified Uncertain significance (May 11, 2022)2390769
1-33094662-C-A not specified Uncertain significance (Dec 07, 2021)2265850
1-33096715-C-T Benign (Dec 28, 2017)788074
1-33096791-T-A not specified Uncertain significance (May 27, 2022)2292329
1-33098091-C-T not specified Uncertain significance (Jun 22, 2021)2218985
1-33098168-A-C not specified Uncertain significance (Sep 07, 2022)2311217
1-33117906-C-A not specified Uncertain significance (Dec 19, 2023)3132510
1-33117959-G-A not specified Uncertain significance (Jun 06, 2023)2557232
1-33118053-T-C not specified Likely benign (Dec 06, 2021)2395136
1-33118062-C-G not specified Uncertain significance (Jan 23, 2024)3132511
1-33118064-T-C not specified Likely benign (Oct 04, 2022)2316887
1-33118106-C-T not specified Uncertain significance (Aug 26, 2022)2402640
1-33120151-G-A not specified Uncertain significance (Jan 31, 2024)3132512

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
AZIN2protein_codingprotein_codingENST00000294517 939427
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
8.87e-70.9261257090391257480.000155
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense0.4672462670.9200.00001473000
Missense in Polyphen6991.5550.753651068
Synonymous0.2901131170.9660.00000726936
Loss of Function1.751321.80.5960.00000112238

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0001520.000152
Ashkenazi Jewish0.000.00
East Asian0.0003260.000326
Finnish0.0002330.000231
European (Non-Finnish)0.00009700.0000967
Middle Eastern0.0003260.000326
South Asian0.0004270.000425
Other0.0001630.000163

dbNSFP

Source: dbNSFP

Function
FUNCTION: Antizyme inhibitor (AZI) protein that positively regulates ornithine decarboxylase (ODC) activity and polyamine uptake. AZI is an enzymatically inactive ODC homolog that counteracts the negative effect of ODC antizymes (AZs) OAZ1, OAZ2 and OAZ3 on ODC activity by competing with ODC for antizyme- binding (PubMed:17900240). Inhibits antizyme-dependent ODC degradation and releases ODC monomers from their inactive complex with antizymes, leading to formation of the catalytically active ODC homodimer and restoring polyamine production (PubMed:17900240). Participates in the morphological integrity of the trans-Golgi network (TGN) and functions as a regulator of intracellular secretory vesicle trafficking (PubMed:20188728). {ECO:0000269|PubMed:17900240, ECO:0000269|PubMed:20188728}.;
Pathway
Arginine and proline metabolism - Homo sapiens (human);putrescine biosynthesis II;Agmatine biosynthesis;Metabolism of polyamines;Metabolism of amino acids and derivatives;Metabolism (Consensus)

Recessive Scores

pRec
0.324

Intolerance Scores

loftool
rvis_EVS
0.0000761
rvis_percentile_EVS
53.98

Haploinsufficiency Scores

pHI
0.427
hipred
N
hipred_score
0.354
ghis
0.521

Essentials

essential_gene_CRISPR
essential_gene_CRISPR2
essential_gene_gene_trap
N
gene_indispensability_pred
gene_indispensability_score

Mouse Genome Informatics

Gene name
Azin2
Phenotype
homeostasis/metabolism phenotype;

Gene ontology

Biological process
spermatogenesis;putrescine transport;putrescine biosynthetic process from ornithine;negative regulation of protein catabolic process;positive regulation of catalytic activity;agmatine biosynthetic process;trans-Golgi network membrane organization;positive regulation of polyamine transmembrane transport
Cellular component
nucleus;cytoplasm;mitochondrion;cis-Golgi network;trans-Golgi network;cytosol;transport vesicle;axon;dendrite;cytoplasmic vesicle;endoplasmic reticulum-Golgi intermediate compartment membrane;perikaryon;perinuclear region of cytoplasm;granular vesicle
Molecular function
ornithine decarboxylase activity;protein binding;arginine decarboxylase activity;putrescine transmembrane transporter activity;ornithine decarboxylase activator activity